Lin Jia

596 total citations
23 papers, 258 citations indexed

About

Lin Jia is a scholar working on Oncology, Molecular Biology and Epidemiology. According to data from OpenAlex, Lin Jia has authored 23 papers receiving a total of 258 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Oncology, 7 papers in Molecular Biology and 6 papers in Epidemiology. Recurrent topics in Lin Jia's work include Cervical Cancer and HPV Research (5 papers), Cancer-related Molecular Pathways (3 papers) and Cancer Treatment and Pharmacology (2 papers). Lin Jia is often cited by papers focused on Cervical Cancer and HPV Research (5 papers), Cancer-related Molecular Pathways (3 papers) and Cancer Treatment and Pharmacology (2 papers). Lin Jia collaborates with scholars based in China, Japan and Macao. Lin Jia's co-authors include Minoru Takagi, Kei Sakamoto, Youzhong Zhang, Qiaojuan Guo, Norihiko Okada, Hui Ren, Yali Wang, Yanping Hu, Jing Wang and Bin Yang and has published in prestigious journals such as Oncotarget, Bioorganic & Medicinal Chemistry and Frontiers in Oncology.

In The Last Decade

Lin Jia

22 papers receiving 245 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Lin Jia China 11 86 70 64 60 32 23 258
Corinne A. Schuyler United States 8 170 2.0× 66 0.9× 37 0.6× 45 0.8× 35 1.1× 8 377
Junyi Guo China 13 147 1.7× 152 2.2× 35 0.5× 31 0.5× 53 1.7× 35 432
Xiaojun Liu China 10 99 1.2× 129 1.8× 44 0.7× 65 1.1× 55 1.7× 30 365
Ayumi Ogawa Japan 8 33 0.4× 57 0.8× 72 1.1× 52 0.9× 37 1.2× 27 250
J. Marruecos Spain 11 98 1.1× 63 0.9× 39 0.6× 52 0.9× 17 0.5× 21 288
Yigang Zhong China 9 23 0.3× 111 1.6× 90 1.4× 41 0.7× 21 0.7× 18 293
Yu–Fu Su Taiwan 9 74 0.9× 121 1.7× 40 0.6× 72 1.2× 51 1.6× 16 298
Anna Synakiewicz Poland 10 44 0.5× 73 1.0× 23 0.4× 112 1.9× 29 0.9× 25 299
Christopher A. Febres‐Aldana United States 10 88 1.0× 110 1.6× 68 1.1× 44 0.7× 33 1.0× 45 327

Countries citing papers authored by Lin Jia

Since Specialization
Citations

This map shows the geographic impact of Lin Jia's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lin Jia with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lin Jia more than expected).

Fields of papers citing papers by Lin Jia

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Lin Jia. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lin Jia. The network helps show where Lin Jia may publish in the future.

Co-authorship network of co-authors of Lin Jia

This figure shows the co-authorship network connecting the top 25 collaborators of Lin Jia. A scholar is included among the top collaborators of Lin Jia based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Lin Jia. Lin Jia is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Xie, Ping, et al.. (2023). Novel, alternative splicing signature to detect lymph node metastasis in prostate adenocarcinoma with machine learning. Frontiers in Oncology. 12. 1084403–1084403. 1 indexed citations
2.
Jia, Lin, Steven J. Isakoff, Marielle Scherrer‐Crosbie, et al.. (2022). An Initial Evaluation of Human Plasma cMLC-1: A Potential Protein Biomarker for Trastuzumab-Induced Cardiotoxicity, Breast Cancer Screening and Progression. Frontiers in Oncology. 12. 809715–809715. 1 indexed citations
3.
Liang, Tingming, et al.. (2022). Inhibition of ALDH2 by disulfiram leads to synthetic lethality via ROS strikes twice in ARID1A-deficient cholangiocarcinoma. Genes & Diseases. 10(1). 69–71. 3 indexed citations
4.
Yang, Ruohan, et al.. (2022). Different treatment regimens in breast cancer visceral crisis: A retrospective cohort study. Frontiers in Oncology. 12. 1048781–1048781. 11 indexed citations
5.
Yang, Ruohan, et al.. (2022). Symptomatic bone marrow metastases in breast cancer: A retrospective cohort study. Frontiers in Oncology. 12. 1042773–1042773. 7 indexed citations
6.
Bai, Rilan, Lin Jia, Yangyang Gao, et al.. (2022). Targeted therapy combined with immunotherapy in patients with breast infiltrating ductal carcinoma with axillary lymph node metastasis of metaplastic SCC. Thoracic Cancer. 13(19). 2799–2807. 2 indexed citations
7.
Liu, Lu, Ying Wang, Xiaoli Liu, et al.. (2021). Computer-aided diagnostic system based on deep learning for classifying colposcopy images. Annals of Translational Medicine. 9(13). 1045–1045. 28 indexed citations
8.
Wang, Jing, et al.. (2020). <p>Tanshinone IIA Promotes Axonal Regeneration in Rats with Focal Cerebral Ischemia Through the Inhibition of Nogo-A/NgR1/RhoA/ROCKII/MLC Signaling</p>. Drug Design Development and Therapy. Volume 14. 2775–2787. 27 indexed citations
10.
Gao, Fei, Lin Jia, Jianjun Han, Jisheng Wang, & Yun Wang. (2018). Predictive value of serum levels of transforming growth factor beta 1 for the short-term effects of radiotherapy and chemotherapy in patients with esophageal cancer. Oncology and Translational Medicine. 4(1). 1–5.
11.
Jia, Lin, Yun Du, Tao Li, et al.. (2015). Differential expression of vascular endothelial growth factor-A, -C and -D for the diagnosis and prognosis of cancer patients with malignant effusions. Oncology Letters. 10(2). 667–674. 11 indexed citations
12.
Zhang, Lu, Qiang Li, Mingyu Zhao, Lin Jia, & Youzhong Zhang. (2015). Discrepancies Between Biopsy-based and Excision-based Grading of Cervical Intraepithelial Neoplasia. International Journal of Gynecological Pathology. 34(3). 221–227. 16 indexed citations
13.
Li, Bo, Qingfu Zhang, Ling Ouyang, et al.. (2013). Aberrant staining patterns of E-cadherin and β-catenin: a potential diagnostic value for distinguishing vulvar intraepithelial neoplasia from non-neoplastic vulvar lesions.. PubMed. 6(7). 1362–6. 6 indexed citations
14.
Jia, Lin, et al.. (2013). Adiponectin suppresses inflammatory responses at the early phase of atherosclerosis in hyperglycemic rats.. PubMed. 3(2). 323–8. 5 indexed citations
16.
Zheng, Hao, et al.. (2012). Synthesis and biological evaluation of novel potent angiotensin II receptor antagonists with anti-hypertension effect. Bioorganic & Medicinal Chemistry. 20(8). 2747–2761. 12 indexed citations
17.
Jia, Lin. (2008). Effect of Tripterygium wilfordii ployglycosidium on Fas/FasL expression in pancreas and spleen of non-obese diabetic mice. 1 indexed citations
18.
Jia, Lin, et al.. (2004). Prognostic value of apoptosis and apoptosis‐associated proteins in salivary gland adenoid cystic carcinoma. Pathology International. 54(4). 217–223. 32 indexed citations
19.
Jia, Lin, et al.. (2003). Comparative study of HPV prevalence in Japanese and North‐east Chinese oral carcinoma. Journal of Oral Pathology and Medicine. 32(7). 393–398. 15 indexed citations
20.
Jia, Lin, et al.. (2000). Comparative Study of Clinicopathological Features of Extranodal Oral Non-Hodgkin's Lymphoma(NHL) and Maxillofacial Nodal NHL.. Oral Medicine & Pathology. 5(1). 15–23. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026